Tranexamic acid

Generic Name
Tranexamic acid
Brand Names
Cyklokapron, Lysteda
Drug Type
Small Molecule
Chemical Formula
C8H15NO2
CAS Number
1197-18-8
Unique Ingredient Identifier
6T84R30KC1
Background

Tranexamic acid is a synthetic derivative of lysine used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to aminocaproic acid but is approximately 10-fold more potent.

It was first patented in 1957 and received its initial US approval in 1986.

Indication

Taken orally, tranexamic acid is indicated for the treatment of hereditary angioedema, cyclic heavy menstrual bleeding in premenopausal females, and other instances of significant bleeding in the context of hyperfibrinolysis. Given intravenously, tranexamic acid is indicated for short-term use (2-8 days) in patients with hemophilia to prevent or reduce bleeding following tooth extraction.

Associated Conditions
Bleeding, Heavy Menstrual Bleeding, Hereditary Angioedema (HAE)
Associated Therapies
-

Combined Administration of Intravenous and Topical Tranexamic Acid in Total Knee Arthroplasty

Phase 1
Conditions
Interventions
First Posted Date
2014-11-10
Last Posted Date
2014-11-10
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
264
Registration Number
NCT02286973

Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section

Phase 4
Conditions
Interventions
First Posted Date
2014-10-30
Last Posted Date
2014-11-04
Lead Sponsor
Ain Shams Maternity Hospital
Target Recruit Count
200
Registration Number
NCT02279186
Locations
🇪🇬

Ain Shams Maternity Hospital, Cairo, Egypt

Tranexamic Acid in Knee Joint Surgery

First Posted Date
2014-10-29
Last Posted Date
2020-05-20
Lead Sponsor
Andrew G Hill, MBChB, MD (Thesis), EdD, FACS, FRACS
Target Recruit Count
150
Registration Number
NCT02278263
Locations
🇳🇿

Auckland Hospital, Auckland, New Zealand

🇳🇿

Manukau Surgery Centre, Auckland, New Zealand

🇳🇿

North Shore Hospital, Auckland, New Zealand

and more 2 locations

Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2014-10-01
Last Posted Date
2022-11-25
Lead Sponsor
Hospital for Special Surgery, New York
Target Recruit Count
89
Registration Number
NCT02253810
Locations
🇺🇸

Hospital for Special Surgery, New York, New York, United States

Prevention of Intraoperative Bleeding and Postoperative Swelling in Orthognathic Surgery Through the Use of Tranexamic Acid

First Posted Date
2014-09-01
Last Posted Date
2017-03-10
Lead Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Target Recruit Count
104
Registration Number
NCT02229292
Locations
🇩🇰

Hospital of South West Denmark, Esbjerg, Denmark

Topical Instillation of Tranexamic Aacid in Bronchoscopy to Decrease Bleeding During Entobronchial & Transbronchial Biopsiy: a Prospective Double Blind Placebo Controlled Study

First Posted Date
2014-08-18
Last Posted Date
2018-06-01
Lead Sponsor
Liran Levy
Target Recruit Count
120
Registration Number
NCT02219152
Locations
🇮🇱

Hadassah Medical Organization, Jerusalem, Israel

Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)

First Posted Date
2014-07-10
Last Posted Date
2023-01-27
Lead Sponsor
Monash University
Target Recruit Count
1310
Registration Number
NCT02187120
Locations
🇦🇺

South Australia Ambulance Service, Eastwood, South Australia, Australia

🇳🇿

St John Ambulance, Albany, New Zealand

🇦🇺

NNSW Medical Retrieval Service, Lismore, New South Wales, Australia

and more 29 locations

Effect of Tranexamic Acid Based on Pharmacokinetics in Pediatric Patients Undergoing Craniosynostosis Surgery: Randomized Controlled Trial

First Posted Date
2014-07-02
Last Posted Date
2016-04-12
Lead Sponsor
Yonsei University
Target Recruit Count
50
Registration Number
NCT02180321
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

Postoperative Bleeding Prevention in Massive Bone Tumour Resection

First Posted Date
2014-06-03
Last Posted Date
2016-09-20
Lead Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Target Recruit Count
56
Registration Number
NCT02153593
Locations
🇪🇸

Hospital Universitario de San Juan de Alicante, Alicante, Spain

🇪🇸

Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

🇪🇸

Hospital Universitario de Cruces, Barakaldo,, Vizcaya, Spain

Comparison of Floseal® and Tranexamic Acid on Bleeding Control After Total Knee Arthroplasty

First Posted Date
2014-06-02
Last Posted Date
2014-06-02
Lead Sponsor
University of Sao Paulo General Hospital
Target Recruit Count
45
Registration Number
NCT02152917
Locations
🇧🇷

Hospital das Clinicas - University of Sao Paulo, Sao Paulo, Brazil

© Copyright 2024. All Rights Reserved by MedPath